tiprankstipranks
Oric Pharmaceuticals (ORIC)
NASDAQ:ORIC
US Market
ORIC
Oric Pharmaceuticals
RESEARCH TOOLSreports
Want to see ORIC full AI Analyst Report?

Oric Pharmaceuticals (ORIC) Income Statement

518 Followers

Oric Pharmaceuticals Income Statement

Last quarter (Q4 2025), Oric Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Oric Pharmaceuticals's net income was $-30.50M. See Oric Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.22M$ -1.11M$ -1.03M$ 0.00$ 0.00
Operating Expenses
$ 141.78M$ 141.79M$ 109.75M$ 91.77M$ 78.87M
Depreciation and Amortization
$ 1.22M$ 1.11M$ 1.03M$ 966.00K$ 897.00K
EBITDA
$ -128.25M$ -126.74M$ -109.75M$ -85.80M$ -77.97M
Operating Income
$ -143.00M$ -142.90M$ -110.78M$ -91.77M$ -78.87M
Other Income/Expenses
$ 13.54M$ 15.05M$ 10.08M$ 2.65M$ 156.00K
Pretax Income
$ -129.47M$ -127.85M$ -100.70M$ -89.12M$ -78.72M
Net Income
$ -129.47M$ -127.85M$ -100.70M$ -89.12M$ -78.72M
Per Share Metrics
Basic EPS
$ -1.47$ -1.83$ -1.96$ -2.25$ -2.07
Diluted EPS
$ -1.47$ -1.83$ -1.96$ -2.25$ -2.07
Weighted Average Shares Outstanding
 87.79M 69.73M 51.45M 39.66M 37.95M
Weighted Average Shares Outstanding (Diluted)
 87.79M 69.73M 51.45M 39.66M 37.95M
Currency in USD

Oric Pharmaceuticals Earnings and Revenue History